Because of controversy regarding the relationship of cytoplasmic ionized calcium concentration (1Ca?2+) to platelet activation, we studied the correlation of platelet aggregation and ATP secretion with ICa2+i as determined by 2-methyl-6-methoxy 8-nitroquinoline (quin2) and aequorin in response to ADP, epinephrine, collagen, the Ca2+ ionophore A23187, and thrombin. Both indicators showed a concentration-dependent increase in [Cai'I in response to all agonists except epinephrine when gel-filtered platelets were suspended in media containing 1 mM Ca22. With epinephrine, a rise in [Ca?'] 
Introduction
It has long been recognized that both extracellular and cytoplasmic ionized calcium are important for platelet activation (1) (2) (3) . Most conclusions regarding the role ofcytoplasmic ionized calcium concentration ([Ca?+]) in platelet shape change, aggregation, and secretion have been based on indirect evidence, including the effect of platelet stimulation on chlortetracycline fluorescence (4), platelet response to Ca2`ionophores (5, 6) , es- timates of 45Ca2+ flux (7) , and comparison of Ca2-dependent and -independent phosphorylation ofproteins (8) . Other studies have employed methods providing access to the cell of external buffers by the use of digitonin or high-voltage electrical current (9, 10) . Although these methods have yielded much valuable information, the lack of a direct nondestructive indicator of [Ca?'] has complicated attempts to correlate platelet activation with [Ca?2] . Furthermore, the recent description of agonist-induced phospholipid breakdown (11) (12) (13) (14) , leading to the activation of protein kinase C at basal [Ca?+] levels (12), has led some investigators to postulate the existence of "Ca2+-independent" pathways to platelet activation (15) .
The first direct indicator of [Car2] in cells too small for microinjection was 2-methyl-6-methoxy 8-nitroquinoline (quin2),' synthesized by Tsien (16) and used to study agonist-induced changes in [Ca'Ij homeostasis in platelets by Rink and colleagues (15, 17) . The capacity of quin2 to buffer both resting Ca2" and transient rises in [Ca?'] ( 18) renders it less than ideal for measuring agonist-induced changes, especially if these were confined to local areas of cytoplasm (19) . Recently, our laboratory has successfully loaded the Ca2+-sensitive photoprotein aequorin (Mr 20,000) into platelets by a nondestructive method and has compared [Ca?+] responses to thrombin and the calcium ionophore A23 187 with those in quin2-loaded platelets (19) . We have suggested that quin2 and aequorin might examine different aspects of[Ca?-+] flux, aequorin having the capability ofmore sensitively detecting localized [Ca?'] elevations, which might not be revealed by the representation of quin2 of average or diffuse [Ca?-+]. Furthermore, the aequorin-loading procedure does not alter subsequent platelet aggregation or secretion in response to stimuli (19) . In the present study, we used these methods to study levels of intraplatelet [Cad+] achieved with varying concentrations of ADP, epinephrine, collagen, ionophore A23 187, and thrombin. The relationship between these measurements and platelet aggregation and ATP secretion was examined, and the effects of chelating extracellular Ca2' with EGTA and ofblocking thromboxane formation with aspirin were assessed.
Methods
Blood collection. Blood was collected from apparently healthy volunteers taking no medications with known platelet-inhibiting properties. 45 ml of free-flowing blood from venipuncture was collected in 50 ml polypropylene tubes containing 5 ml of trisodium citrate (0.130 M). The sample was centrifuged at 2,000 g for 2 min at 20'C in a model PR 2 centrifuge (International Equipment Co., Boston, MA). Platelet-rich plasma (PRP) was then aspirated into a separate polypropylene tube for loading with either quin2 or aequorin. For studies of aspirin-treated platelets, 1 mM acetyl salicylic acid was added to PRP and incubated Quin2 loading. In the samples used for measurement of [Cai'] with quin2, PRP was incubated for 15 min with 5-10 AM quin2 acetoxymethyl ester to produce a final intracellular quin2 (acid form) concentration of 0.7-1.0 mM (mean: 0.86), as previously described (19) . After the incubation, prostaglandin E, (PGE1) (I AM, final concentration) was added to the sample, which was then centrifuged at 432 g at 200 for 15 min. The supernatant was discarded and the pellet was resuspended in I ml of modified Hepes-Tyrode's buffer, prepared as described previously (19) . The suspension was then gel-filtered through a 10-ml bed volume Sepharose 2B column preequilibrated with modified Hepes-Tyrode's buffer, containing EGTA (10 AM) and no added Ca2". The effluent platelet suspension was diluted with Hepes-Tyrode's buffer containing Ca2" 1 mM to achieve a final platelet count of I X 108 platelets/ml and incubated for 30-45 min at 370C before fluorescence measurements were begun.
In experiments designed to demonstrate the effect of Ca2" chelation by quin2 on aggregation and aequorin luminescence, platelets were loaded with higher concentrations of quin2 (mean: 2.9 mM) and the platelets were then loaded with aequorin, as described below. After being loaded with both aequorin and quin2, the platelets continued to retain over 90% ofthe total quin2 in the suspension, as assessed by addition ofMn2+ 30 AM (19) . Agonist-induced changes in quin2 fluorescence were unchanged from those seen in platelets loaded with quin2 only. The concentration of intracellular quin2 was determined as described previously (19) .
Aequorin loading. Our method for loading platelets with aequorin has been described and characterized in detail (19) . In brief, a platelet pellet (prepared by centrifugation from PRP) was washed and resuspended in 500 Al of Hepes-Tyrode's buffer containing 10 mM EGTA and I AM PGE1. After centrifugation, the platelets were resuspended in 300 MI of a solution containing EGTA (10 mM) MgCI2 (2 mM), ATP (5 mM), and aequorin, 0.2 mg/ml (solution A; see Johnson et al. [19] ). This suspension was incubated at 0C for 60 min, and then recentrifuged. The platelets were resuspended in a solution containing a 0.1 mM EGTA10mM MgC12 (solution B) and reincubated for 60 min. CaC12 was added to the suspension (300 AM, final concentration); the platelets were warmed to room temperature and gel-filtered in Hepes-Tyrode's buffer containing Ca2+ 1 mM. The eluent was diluted with the same buffer, so that most studies were conducted with 5-ml aliquots containing 6 X 108 platelets (range 5 X 107 to 1 X 109). In some experiments, 6-carboxy fluorescein (1 mM) was added with solution A to the platelet suspension instead of aequorin, and the platelets were examined by fluorescence microscopy and by flow cytometry. In experiments involving selective digitonin lysis, 14C-labeled 5-hydroxy tryptamine was incubated with PRP before the platelets were loaded with aequorin. After selective digitonin lysis, a portion of the platelet supernatant was taken for lactic dehydrogenase determinations.
[Ca?+] measurements (quin2). Aliquots of 1.6 ml of platelet suspension containing 1 X 108 platelets/ml were placed into spectroscopy cuvettes (Evergreen, Los Angeles, CA) which were inserted into a temperature-controlled (370) spectrophotofluorimeter (Aminco-Bowman, model J4-891 IA American Instrument Co., Silver Springs, MD) with a magnetic stirrer. Agonists were added through a light-tight porthole above the sample, and signals were recorded on a Hewlett-Packard 7044 recorder (Hewlett-Packard Co., Palo Alto, CA) with a noise-reduction filter (Pomona Electronics, Pomona, CA). Calibration and determination of [Cai'] levels were done as described by Tsien et al. (16, 18) using the ratio of platelet fluorescence (excitation 339 nm, emission 500 nm), to peak fluorescence (Fag) generated by Triton-induced cell lysis multiplied by the dissociation constant (Kd) of quin2 for Ca2'. Changes in platelet autofluorescence produced by addition of agonists, Triton, or EGTA to non-quin2-loaded platelets were subtracted or added as appropriate to the fluorescent signal obtained in quin2-loaded platelets before [Ca?+] was calculated, as illustrated by Tsien et al. (20) .
[Ca"]J measurements (aequorin). 5 ofaequorin-loaded platelets suspended in 1 mM Ca2"-containing media and the resultant luminescent spike was compared with that produced by subsequent addition of Triton X-100 to produce complete lysis of platelet organelles. Digitonin (20 gM) released 95% ofthe total aequorin in the sample; concentrations of 50 ,tM or greater released 100% of the aequorin. These concentrations ofdigitonin are much below those that lysed platelet granules or membranes of the dense tubular system (200 uM) (22) , indicating that active aequorin does not enter these structures either during or after the loading procedure. At digitonin concentrations of 50 ztM, 30% of the total amount of lactic dehydrogenase, a cytoplasmic enzyme, was released, suggesting that the aequorin is located in the cytoplasm. However, we cannot rule out the possibility that some portion of the aequorin is concentrated in a compartment of the platelet that is highly sensitive to digitonin (perhaps just under the plasma membrane).
Typical [Cad+] signals in response to thrombin (0.01 U/ml) with platelets loaded with aequorin or quin2 are seen in Fig. 1 In response to ionophore A23187 (Fig. 5) Fig. 2 panied functional changes as well, but, in several instances (collagen and epinephrine), aggregation and secretion occurred without elevation of the quin2 signal. This latter finding has been reported by others (15, 17, 27) and has been offered as evidence of the existence of a "Ca2'-independent" pathway to platelet activation (15, 17, 28 [Ca? '] [Call] signals and aggregation in platelets loaded with aequorin, quin2, or both indicators. All tracings were obtained from platelets suspended in media containing Ca21, I mM. In A, the top and middle tracings represent the response of aequorin-loaded platelets to epinephrine (E), 10 MM; a parallel sample of platelets loaded with quin2 (0.85 mM) is seen on the bottom. Fibrinogen (Fg) 400 jsg/ ml was added to the platelet sample before epinephrine. In B, similar tracings were obtained in platelets loaded with both aequorin and quin2 (2.9 mM). Addition of very high quin2 concentrations delayed and decreased, but did not eliminate, rises in aequorin-indicated
[Call] and aggregation. In neither A nor B was a rise in quin2 fluorescence seen. In C, the top and middle tracings were produced by stimulation of aspirin-treated aequorin-loaded platelets by collagen (C), 10 Ag/ml; the bottom tracing represents a parallel sample of aspirintreated quin2 (0.78 mM)-loaded platelets. Similar tracings obtained with aspirin-treated platelets loaded with both aequorin and quin2 (2.9 from aequorin discharge in a few damaged, and hence permeable, cells (19) . Although we still cannot discard these possibilities, the results from the experiments in which plasma membranes were selectively lysed with digitonin, as described by Akkerman et al. (22) , suggest that platelet granules do not contain a measurable quantity of undischarged aequorin. This does not necessarily establish that aequorin is freely diffusable in the platelet cytoplasm; in fact, the very low concentrations of digitonin required to release >90% of the aequorin might suggest that it is located superficially, perhaps just under the plasma membrane, which may fortuitously be an area of high [Ca?'] concentration (37) . The experiments in which 6-carboxy-fluorescein was uniformly loaded into platelets suggest that, if one assumes that aequorin is loaded by a process similar to this compound, the vast majority of platelets are at least capable of contributing to the aequorin-indicated [Cal'] signal. Further work is necessary before these possible artifacts can be confidently discarded. When EGTA was added to chelate external Ca2+, all agonists (except epinephrine) continued to generate concentration-dependent increases in aequorin luminescence. However, aequorin responses generated by thrombin, ADP, A23 187, and collagen were less in EGTA than in Ca2`media, indicating that increased permeability to extracellular Ca2" may be one component of platelet activation by these agonists. Alternatively, other investigators have found that EGTA inhibits phospholipase C activity (38) , which could limit platelet activation by some agonists, presumably by decreasing formation of metabolites with ionophoric properties and, indirectly, arachidonic acid (39) . The finding that all of the agonists (except epinephrine) could mobilize intracellular Ca2`in aspirin-treated platelets, and that these [Calf] increases correlated with functional changes, offers support to the findings of Packham et al. (40) , who found evidence for a dominant third pathway to platelet activation by thrombin and A23187 unassociated with cyclooxygenase metabolites. The present study suggests that this third pathway may be closely linked to mobilization of intracellular Ca2+. The [Caj2+] signals reported by aequorin in response to ADP were much lower than those generated by moderate concentrations of collagen or thrombin, which correlates with their comparative effects on aggregation and phosphoinositide turnover (41) . Both EGTA and aspirin decreased the aequorin-indicated [Ca2+] response. Influx ofextracellular Ca2' may be crucial only during secondary aggregation due to ADP, as predicted by 45Ca2+ studies (7, 42) ; however, the binding of extracellular Ca2`to the platelet surface appears to be necessary for the earliest stages of platelet activation by ADP or epinephrine (43 In experiments using collagen as an agonist, there was a marked discrepancy between concentrations at which aequorin and quin2 signals were produced in the absence of extracellular Ca2+ or with aspirin (Fig. 4) The differences between quin2 and aequorin-indicated [Ca?2] in collagen and epinephrine-treated platelets were further investigated in experiments using platelets loaded with both indicators, with a much higher quin2 concentration than was used in the other experiments so that the effect of increased Ca2" chelation could be assessed (Fig. 7) . Addition of quin2 delayed and decreased both aggregation and the aequorin-indicated peak 
